NDC 64380-187

Zafirlukast

Zafirlukast

Zafirlukast is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Strides Pharma Science Limited. The primary component is Zafirlukast.

Product ID64380-187_2b8fd447-3b4a-4f31-b67a-edf6c67809b4
NDC64380-187
Product TypeHuman Prescription Drug
Proprietary NameZafirlukast
Generic NameZafirlukast
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2022-08-08
Marketing CategoryNDA /
Application NumberNDA020547
Labeler NameStrides Pharma Science Limited
Substance NameZAFIRLUKAST
Active Ingredient Strength10 mg/1
Pharm ClassesCytochrome P450 2C9 Inhibitors [MoA], Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 64380-187-01

60 TABLET, COATED in 1 BOTTLE (64380-187-01)
Marketing Start Date2022-08-08
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Zafirlukast" or generic name "Zafirlukast"

NDCBrand NameGeneric Name
0904-6646Zafirlukastzafirlukast
16571-654ZafirlukastZafirlukast
16571-655ZafirlukastZafirlukast Tablets
31722-007ZafirlukastZafirlukast
31722-008ZafirlukastZafirlukast
49884-549Zafirlukastzafirlukast
49884-554Zafirlukastzafirlukast
50268-805ZafirlukastZafirlukast
55111-625ZafirlukastZafirlukast
55111-626ZafirlukastZafirlukast
63629-2102Zafirlukastzafirlukast
64380-187Zafirlukastzafirlukast
64380-188Zafirlukastzafirlukast
68084-059ZafirlukastZafirlukast
68151-1977ZafirlukastZafirlukast
49884-010ACCOLATEzafirlukast
49884-011ACCOLATEzafirlukast
49884-589Accolatezafirlukast
49884-590Accolatezafirlukast
53808-0203ACCOLATEZafirlukast

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.